Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans

Molecular Pharmacology

Volumn 60, Issue 2, 2001, Pages 382-387

  Dickmann, Leslie J ^a   Rettie, Allan E ^a   Kneller, M Byron ^a   Kim, Richard B ^b   Wood, Alastair J J ^b   Stein, C Michael ^b   Wilkinson, Grant R ^b   Schwarz, Ute I ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOCHROME P450 2C9; DICLOFENAC; LAURIC ACID; WARFARIN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; DNA POLYMORPHISM; GENE EXPRESSION; GENE MUTATION; HUMAN; HYDROXYLATION; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; PROTEIN VARIANT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0034921210     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.2.382     Document Type: Article

References (35)

1. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
2. High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: A review and preliminary data
3. Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-Ile359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation
4. The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH: Cytochrome P450 oxidoreductase
5. Oxygenated cytochrome P-450 as an intermediate in hydroxylation reactions
6. Pharmacogenomics: Translating functional genomics into rational therapeutics
7. Biochemistry and molecular biology of the human CYP2C subfamily
8. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences
9. Cytochrome P450-dependent desaturation of lauric acid: Isoform selectivity and mechanism of formation of 11-dodecenoic acid
10. Allelic variants of human cytochrome P450 2C9: Baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms
11. Enzymatic determinants of the substrate specificity of CYP2C9: Role of B′-C loop residues in providing the pi-stacking anchor site for warfarin binding
12. 'Cold SSCP': A simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses
13. Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis
14. Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: Genetic analysis of the CYP2C9 locus
15. Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele
16. Highly sensitive and specific high-performance liquid chromatographic analysis of 7-hydroxywarfarin, a marker for human cytochrome P-4502C9 activity
17. CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles
18. A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: Association with diminished debrisoquine hydroxylase activity
19. Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174
20. Cytochrome P4502C9: An enzyme of major importance in human drug metabolism
21. Structural flexibility and functional versatility of cytochrome P450 and rapid evolution
22. Genetic polymorphism of the CYP2C subfamily and excessive serum phenytoin concentration with central nervous system intoxication
23. A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin
24. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
25. Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C5
26. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes
27. Ethnicity as a variable in epidemiological research
28. Genetic association between sensitivity to warfarin and expression of CYP2C9*3
29. Genetic analysis of the human cytochrome P450 CYP2C9 locus
30. The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism
31. CYP2C9 Ile359 and Leu359 variants: Enzyme kinetic study with seven substrates
32. The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol
33. Ethnic differences in drug disposition and response
34. Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes
35. Validation of methods for CYP2C9 genotyping: Frequencies of mutant alleles in a Swedish population